The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco
Author(s) -
Khadija Bakhouch,
A. Ouladlahcen,
Rajae Bensghir,
Mohamed Blaghen,
Kamal Marhoum Elfilali,
Sayeh Ezzikouri,
Omar Abidi,
Mohamed Hassar,
Lahcen Wakrim
Publication year - 2009
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.247
Subject(s) - reverse transcriptase , virology , drug resistance , subtyping , resistance mutation , protease , mutation , biology , transmission (telecommunications) , medicine , gene , polymerase chain reaction , genetics , enzyme , biochemistry , computer science , electrical engineering , programming language , engineering
The widespread use of antiretroviral agents and the growing occurrence of HIV-1 strains resistant to these drugs have given rise to serious concerns regarding the transmission of resistant viruses to newly infected persons, which may reduce the efficacy of a first-line antiretroviral therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom